Prosper Junior Bakiny
TMFPBakiny
Prosper Junior Bakiny is a contributing Motley Fool Healthcare Analyst. Before The Motley Fool, Prosper wrote content for various companies, covering everything from stock market news to private equity investing. He holds an M.S. in Corporate Finance from the University of Maryland Global Campus. Fun fact: French is Prosper’s first language.
Recent Articles by Prosper Junior Bakiny

Feb 15, 2025
by Prosper Junior Bakiny
Is Teladoc Stock a Buy?

Feb 10, 2025
by Prosper Junior Bakiny
2 Stocks to Buy With Less Than $40

Feb 9, 2025
by Prosper Junior Bakiny
Is Summit Therapeutics a Millionaire Maker?

Feb 8, 2025
by Prosper Junior Bakiny
2 Stocks That Could Soar Again in 2025

Feb 7, 2025
by Prosper Junior Bakiny
Is CVS Health's Dividend Safe?

Feb 5, 2025
by Prosper Junior Bakiny
2 Monster Stocks to Buy and Hold Forever

Feb 3, 2025
by Prosper Junior Bakiny
The Best Stock to Invest in With $500

Feb 2, 2025
by Prosper Junior Bakiny
Is Johnson & Johnson Stock a Buy?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.